肺炎链球菌胞外囊泡对小鼠鼻定植及侵袭性感染的保护作用及PspA的作用
研究评估非荚膜肺炎链球菌株R6来源胞外囊泡(pEVs)的免疫原性与保护潜力,采用小鼠定植与侵袭性肺炎模型。皮下免疫对PspA产生高抗体反应,对PrsA反应 modest,对Ply、MalX和PsaA反应有限;皮下免疫在侵袭性肺炎模型中提供保护,鼻免疫使上呼吸道定植减少1个log;PspA是侵袭模型保护的主要贡献者,并跨异源PspA家族提供一定程度保护。
要点
- pEVs皮下免疫对PspA产生高抗体反应,对PrsA反应 modest,对Ply、MalX和PsaA反应有限。
- pEVs皮下免疫在侵袭性肺炎模型中提供保护,鼻免疫使上呼吸道定植减少1个log。
- PspA是侵袭模型保护的主要贡献者,跨异源PspA家族提供一定程度保护。
核心结论
- pEVs展示出疫苗开发潜力,可跨荚膜型提供保护,并跨异源PspA变体提供一定程度保护。
研究设计与样本
- 使用非荚膜肺炎链球菌株R6来源的胞外囊泡(pEVs),在小鼠肺炎链球菌定植和侵袭性肺炎模型中评估免疫原性与保护潜力。
主要发现
- 皮下免疫对PspA产生高抗体反应,对PrsA反应 modest,对Ply、MalX和PsaA反应有限。
- pEV免疫小鼠血清可凝集肺炎链球菌,PspA以菌株依赖方式贡献此反应。
- 皮下免疫在侵袭性肺炎模型中提供保护,鼻免疫使上呼吸道肺炎链球菌定植减少1个log。
- PspA是侵袭模型保护的主要贡献者,并跨异源PspA家族提供一定程度保护。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diseases caused by Streptococcus pneumoniae (pneumococcus) produce a great impact on public health, killing about one million people annually despite available vaccines. Recent research has revealed that the pneumococcus produces extracellular vesicles (pEVs), which display selective cargo and hold potential for vaccine development. Here, we evaluated the immunogenicity and protective potential of pEVs derived from a non-encapsulated pneumococcal strain (R6) using murine models of pneumococcal colonization and invasive pneumonia. Characterization of the immune response revealed that while pEVs contain multiple virulence determinants, immunization with these nanoparticles only induces antibodies against a subset of them. Specifically, subcutaneous immunization elicits a high antibody response against PspA, a modest response against PrsA, and limited response against Ply, MalX and PsaA. The antibody response was further supported by agglutination studies, showing that sera from pEV immunized mice agglutinate pneumococci and that PspA contributes to this response in a strain-dependent manner. Subcutaneous immunization with pEVs provides protection in the invasive pneumonia model whereas nasal immunization results in one log reduction in pneumococcal colonization of the upper respiratory tract. Finally, PspA is a strong contributor to protection in the invasive model and provides a degree of protection even across heterologous families of PspA. We conclude that pEVs demonstrate potential for vaccine development, protecting across capsular types and providing some degree of protection across heterologous PspA variants.
引用
- Carneiro GB, Yerneni SS, Chinaia K, et al. Protection induced by Streptococcus pneumoniae extracellular vesicles against nasal colonization and invasive infection in mice and the role of PspA. Vaccine. 2024. PMID: 39617674. doi:10.1016/j.vaccine.2024.126566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。